RecruitingNot ApplicableNCT07140575

rTMS for Youth Inpatients With Depression

Seamless Integration of Repetitive Transcranial Magnetic Stimulation (rTMS) for Youth Inpatients With Depression: A Feasibility Study


Sponsor

Sunnybrook Health Sciences Centre

Enrollment

30 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Youth aged 15-24 are likelier to have depression than all age groups in Canada. One-third of depressed youth do not respond to psychotherapy and/or antidepressant medications. A treatment called repetitive transcranial magnetic stimulation or rTMS has proven helpful in adolescents and young adults whose depressive symptoms have been difficult to treat with psychotherapy and/or antidepressants. Unfortunately, youth find rTMS difficult to access because it is not funded by the Ontario Health Insurance Plan, is typically only offered to adults, and the treatment schedule usually involves once-daily sessions, 5 days/week, for 4-6 weeks, which is associated with travel and opportunity costs e.g. missing school. This project looks at the feasibility of a new treatment pathway that allows youth with difficult-to-treat depression in hospital to receive rTMS twice-daily while engaging in on-unit schooling and therapeutic support. This "accelerated" way of providing rTMS is safe, has equal effectiveness to once-daily rTMS, and can shorten the time needed for treatment. This pathway is for youth already staying in hospital for difficult-to-treat depression or youth outside hospital who have difficult-to-treat depression that interferes with daily function to such a degree that they would benefit from staying in hospital. The investigators anticipate integrating rTMS and inpatient care for youth will be feasible, that it will be acceptable and accessible to youth and families, and there will be sufficient demand for this new treatment pathway. If successful, this project will inform care for youth with difficult-to-treat depression in Ontario and beyond.


Eligibility

Min Age: 14 YearsMax Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This study is testing repetitive transcranial magnetic stimulation (rTMS) — a non-invasive brain stimulation treatment — in teenagers and young adults hospitalized for depression. The goal is to see if rTMS reduces depressive symptoms in young patients who have not responded well to therapy or antidepressants. **You may be eligible if...** - You are 14 to 19 years old - You have a primary diagnosis of major depressive disorder or bipolar disorder (current depressive episode, without psychotic or mixed features) - Your current depressive episode has lasted at least 4 weeks - You have tried and not responded to at least one evidence-based therapy or antidepressant - Your depression is moderate to severe - You are currently hospitalized or suitable for elective inpatient admission **You may NOT be eligible if...** - You have a history of psychosis, anorexia nervosa, or bulimia nervosa - You have a current substance use disorder - You have active psychosis or mania - You have a diagnosis of obsessive compulsive disorder or personality disorder as the primary driver of your symptoms Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICErepetitive transcranial magnetic stimulation (rTMS)

twice daily rTMS, intermittent theta burst stimulation targeting the left dorsolateral prefrontal cortex with a figure-8 coil


Locations(1)

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07140575


Related Trials